Chief Business Development H/F - FIRALIS

Firalis Molecular Precision is a Contract Research Organization (CRO) offering a range of tailored and innovative solutions to pharmaceutical and biotechnology companies, researchers and healthcare professionals to help them develop their drugs and advance their research. Our services include sample storage and management, bioanalytical testing, omics data analysis and interpretations. Firalis Molecular Precision SA is part of Janvier Bioscience Group.Firalis Molecular Precision, member of Janvier Group Biosciences is a fast-growing Contract Research Organization (CRO) specializing in multi-omics services, with a strong focus on proteomics and genomics. We support Big Pharma, biotech companies, and academic institutions in biomarker discovery, translational research, and precision medicine by delivering high-quality, scientifically rigorous, and innovative omics solutions.

Position Overview

We are seeking a Business Development Manager / Chief Business Development Officer (CBDO) to define and execute the global business development strategy of the company. The position is 5% Strategy, 95% Operation. The ideal candidate will combine deep scientific and technical expertise in proteomics, genomics, and biomarkers with a strong commercial mindset and proven experience in selling complex scientific services to pharmaceutical, biotech, and academic clients.

As a key member of the executive leadership team, the BDM/CBDO will play a critical role in driving revenue growth, expanding strategic partnerships, and positioning the company as a leading multi-omics CRO.

Key Responsibilities (role is 5% Strategic / 95% Operation)

Strategic Leadership

- Define and execute the global business development and commercial strategy aligned with the company's scientific capabilities and mid-term/long-term vision.
- Identify new market opportunities in proteomics, genomics, biomarker discovery, translational research, and precision medicine.
- Contribute to corporate strategy, pricing models, and service portfolio evolution.

Business Development & Sales

- Lead and grow business relationships with Big Pharma, biotech companies, and academic institutions.
- Drive the full sales cycle: lead generation, scientific discussions, proposal development, contract negotiation, and deal closing.
- Build long-term strategic partnerships and key accounts.
- Represent the company at scientific conferences, partnering events, and industry meetings.

Scientific & Technical Engagement

- Act as a scientific ambassador of the company, capable of engaging in high-level technical discussions with clients.
- Translate complex proteomics and genomics technologies into clear value propositions.
- Collaborate closely with scientific, bioinformatics, and operations teams to design customized solutions for clients.
- Ensure scientific credibility in discussions related to biomarkers, validation, data interpretation, and regulatory considerations.

Team & Cross-functional Collaboration

- Drive by example
- Build, mentor, and lead the business development and sales team.
- Work closely with R&D, project management, and executive teams to ensure successful project delivery and client satisfaction.
- Provide market feedback to guide technology development and service innovation.

Required Qualifications

Education & Scientific Expertise

- PhD, PharmD, MD, or MSc with significant experience in proteomics, genomics, molecular biology, or related life sciences.
- Strong understanding of:
- Proteomics technologies (e.g., Olink, quantitative proteomics, biomarker validation)
- Genomics technologies (e.g., NGS, transcriptomics, single cell analysis)
- Biomarker discovery, validation, and clinical/translational applications
- Clinical studies requirements (Ph1 to 3)

Professional Experience

- 8+ years of experience in business development, commercial roles, or scientific sales within a CRO, biotech, pharma, or life science services environment.
- Multiomics experience and clinical network in large pharma preferred
- Proven track record of closing complex, high-value deals with pharma and biotech clients.
- Previous leadership is a plus.